Search
Daphne Zohar on becoming the CEO of Seaport Therapeutics and today's $100M series A
- blonca9
- Apr 9, 2024
- 1 min read
She describes working with Steven Paul again, the Glyph technology that is the backbone of Seaport's platform, and initial programs in the neuropsychiatry space.